Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bonelli

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Arthritis Research & Therapy|August 27, 2015
Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritisStephan Blüml, Emine Sahin, Victoria Saferding, et al.
The Journal of Experimental Medicine|September 13, 2023
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signalingLisa Sandner, Marlis Alteneder, Ramona Rica, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
Rheumatology (Oxford, England)|November 18, 2021
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritisPaul Studenic, Gregor Bond, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|June 10, 2026
Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapyTeresa Preglej, Anela Tosevska, Marie Brinkmann, et al.
Immunity|May 21, 2015
Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine SpecificityKiyoshi Hirahara, Atsushi Onodera, Alejandro V Villarino, et al.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Arthritis Research & Therapy|August 27, 2015
Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritisStephan Blüml, Emine Sahin, Victoria Saferding, et al.
The Journal of Experimental Medicine|September 13, 2023
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signalingLisa Sandner, Marlis Alteneder, Ramona Rica, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
Rheumatology (Oxford, England)|November 18, 2021
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritisPaul Studenic, Gregor Bond, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|June 10, 2026
Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapyTeresa Preglej, Anela Tosevska, Marie Brinkmann, et al.
Immunity|May 21, 2015
Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine SpecificityKiyoshi Hirahara, Atsushi Onodera, Alejandro V Villarino, et al.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Pageof 8